In This Article:
The United Kingdom's FTSE 100 index recently closed lower, influenced by weak trade data from China, which has struggled to recover from the pandemic. Amid this backdrop, investors are seeking high-growth tech stocks that can thrive despite broader market uncertainties and economic headwinds.
Top 10 High Growth Tech Companies In The United Kingdom
| Name | Revenue Growth | Earnings Growth | Growth Rating |
|---|---|---|---|
| STV Group | 13.15% | 46.78% | ★★★★★☆ |
| Gaming Realms | 11.57% | 22.07% | ★★★★★☆ |
| YouGov | 14.29% | 29.79% | ★★★★★☆ |
| Facilities by ADF | 52.00% | 144.70% | ★★★★★☆ |
| Redcentric | 4.89% | 63.79% | ★★★★★☆ |
| Windar Photonics | 63.60% | 126.92% | ★★★★★☆ |
| LungLife AI | 100.61% | 100.97% | ★★★★★☆ |
| Beeks Financial Cloud Group | 24.63% | 57.95% | ★★★★★☆ |
| Oxford Biomedica | 20.98% | 106.13% | ★★★★★☆ |
| Vinanz | 113.60% | 125.86% | ★★★★★☆ |
Click here to see the full list of 48 stocks from our UK High Growth Tech and AI Stocks screener.
We're going to check out a few of the best picks from our screener tool.
Nexxen International
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Nexxen International Ltd. offers an end-to-end software platform that enables advertisers to reach publishers in Israel, with a market cap of £398.10 million.
Operations: Nexxen International Ltd. generates revenue primarily through its marketing services, amounting to $339.02 million. The company facilitates connections between advertisers and publishers in Israel using its comprehensive software platform.
Nexxen International's recent strategic maneuvers, including a significant partnership with The Trade Desk and Vevo, underscore its innovative approach in the tech sector. By integrating ACR data segments for enhanced advertising capabilities, Nexxen is not just expanding its digital footprint but also solving critical challenges in CTV advertising like over-saturation and fragmented targeting. Financially, after a robust second quarter showing sales growth to $88.58 million from $84.25 million last year and flipping a net loss into a $2.92 million profit, the company is on an upward trajectory. This performance aligns with an expected annual earnings growth of 71.9%, positioning Nexxen favorably against slower market trends.
Genus
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Genus plc is an animal genetics company with operations across North America, Latin America, the United Kingdom, Europe, the Middle East, Russia, Africa, and Asia and has a market cap of £1.30 billion.
Operations: Genus plc generates revenue primarily through its Genus ABS and Genus PIC segments, contributing £314.90 million and £352.50 million respectively. The company operates extensively across multiple continents including North America, Latin America, Europe, the Middle East, Russia, Africa, and Asia.